Organogenesis
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 862
- Market Cap
- -
- Introduction
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Other: Affinity AllograftOther: Standard of care
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 89
- Registration Number
- NCT02880592
- Locations
- 🇺🇸
GF Professional Research, Miami Lakes, Florida, United States
🇺🇸Barry University Clinical Research, North Miami Beach, Florida, United States
🇺🇸Henry Ford Macomb Hospital, Clinton Township, Michigan, United States
Study of Nucel for One and Two Level Lumbar Interbody Fusion
- Conditions
- SpondylolisthesisDegenerative Disc DiseaseSpondylosis
- Interventions
- Procedure: One or two level lumbar interbody fusion surgeryOther: Nucel
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 200
- Registration Number
- NCT02808234
- Locations
- 🇺🇸
Florida Orthopaedic Insitute, Tampa, Florida, United States
🇺🇸Spine Institute of Louisiana, Shreveport, Louisiana, United States
🇺🇸Carolina Neurosurgery & Spine, Charlotte, North Carolina, United States
A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®
- Conditions
- Venous Leg Ulcers
- Interventions
- Device: Apligraf
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 100
- Registration Number
- NCT02011724
- Locations
- 🇺🇸
Winthrop University Hospital, Mineola, New York, United States
Safety Study of Gintuit™ in Subjects Requiring Socket Grafting
- Conditions
- Edentulous Alveolar Ridge
- Interventions
- Biological: GintuitDevice: Bio-Gide
- First Posted Date
- 2013-08-28
- Last Posted Date
- 2015-09-24
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 5
- Registration Number
- NCT01929954
- Locations
- 🇺🇸
Kevin G. Murphy and Associates, P.A., Baltimore, Maryland, United States
A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva
- Conditions
- Gingival Recession
- Interventions
- Device: GintuitOther: autologous Free Gingival Graft (FGG)
- First Posted Date
- 2012-03-08
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 25
- Registration Number
- NCT01547962
- Locations
- 🇺🇸
PerioHealth, Houston, Texas, United States
A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers
- Conditions
- Venous Ulcer
- Interventions
- Device: ApligrafOther: Standard of Care Dressing Group
- First Posted Date
- 2011-04-04
- Last Posted Date
- 2015-09-24
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 30
- Registration Number
- NCT01327937
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds
- Conditions
- Wounds
- Interventions
- Device: VCT-01
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 3
- Registration Number
- NCT01292122
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Device: DermagraftOther: Comparator
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2018-05-21
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 314
- Registration Number
- NCT01181453
- Locations
- 🇺🇸
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Other: Conventional careDevice: Dermagraft(R)
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2018-05-21
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 281
- Registration Number
- NCT01181440
- Locations
- 🇺🇸
Richard Pollak, DPM, San Antonio, Texas, United States
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
- Conditions
- Venous Leg Ulcer
- Interventions
- Device: Dermagraft(R)Device: Profore
- First Posted Date
- 2009-05-29
- Last Posted Date
- 2018-06-18
- Lead Sponsor
- Organogenesis
- Target Recruit Count
- 537
- Registration Number
- NCT00909870
- Locations
- 🇺🇸
Coastal Clinical Research, Inc., Mobile, Alabama, United States
🇺🇸Carl T. Hayden VA Medical Center, Phoenix, Arizona, United States
🇺🇸HOPE Research Institute, Phoenix, Arizona, United States